Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry headquartered in Germany, ha...
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under fi...
AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being releas...
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...
Swiss high-tech company ZENUM has developed one of the most advanced technologies in the fight against Covid-19, and it ...
NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...
A new variant of the virus that causes COVID-19 (SARS-CoV-2) has been identified across the South East of England. The v...
US based Gamma Biosciences, a life sciences tools platform created by KKR, has announced a licensing agreement between A...
The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Health of th...
EUROIMMUN, a PerkinElmer, Inc. Company, has announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza...
Logistics4Pharma, a German pharmaceutical logistics and cold chain specialist, recently completed a successful inspectio...
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. has announced that the extr...
Vetter, a global leading Contract Development and Manufacturing Organization (CDMO) is continuously investing in climate...
Becton, Dickinson and Company (BD) has announced plans to invest approximately $1.2 billion over a 4-year period to expa...
France-based Kayentis, a global provider of digital data capture systems for clinical trials, on 2 Dec 2020 announc...
Pfizer Inc. and BioNTech SE have announced that the Medicines & Healthcare Products Regulatory Agency (MHR...
Eppendorf offers now a further building block in supporting scientists with tailored solutions for the daily lab routine...
Switzerland based Bioversys has recently reached a major milestone by entering clinical development with the start of Ph...
